Karyopharm Therapeutics | KPTI - Ebitda

Preço das Ações
8.00
Mudança Diária
-0.16 -1.96%
Mensal
-8.57%
Anual
86.48%
Q2 Previsão
7.78




Ebitda Alterar Data
AbbVie USD 3.52B 828M 2025-09
Abbott USD 3.09B 44M 2025-09
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Incyte USD 414.5M 92.42M 2025-12
J&J USD 9.52B 389M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD 21.95M 55.39M 2025-09
Merck USD 8.39B 1.97B 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Novartis USD 4.77B 1.11B 2025-12
Novartis USD 5.84B 235M 2025-09
Pfizer USD 6.08B 351M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Takeda JPY 448.13B 173.98B 2025-12
Tectonic Therapeutic USD -21.18M 365K 2025-12
TG Therapeutics USD 32.69M 5M 2025-09
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
Xencor USD -51.05M 55.28M 2025-12